Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance

Abeona Therapeutics Inc
YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

Price performance

Price movement over the last 24 hours

Key statistics

Abeona Therapeutics Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $40.26. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.

ABEOQDTY
Market Cap
$373.32M
Sector
HealthIncome / Options Overlay
52-Week High
$7.23$46.71
52-Week Low
$4.17$36.57
Enterprise Value
$228.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abeona Therapeutics Inc

ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.

Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY trades at $41.16, up 1.66% today, but technical indicators signal a bearish trend with moving averages and overall signals pointing lower. The stock exhibits weekly dividend distributions, with recent payouts ranging from $0.22 to $0.32. Support and resistance levels are clustered near the current price, indicating potential volatility. Recent news focuses heavily on dividend announcements from YieldMax ETFs, with minimal coverage of broader business performance or financial results.

The outlook remains cautious due to weak technical momentum and lack of fundamental data. Investment opportunity hinges on dividend yield sustainability, but risks include absence of earnings visibility and bearish technical pressure. Key catalysts for reversal would require positive earnings surprises or upward analyst revisions, which are currently unavailable.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.

Read more on QDTY